title: Efficacy of treatment with tetracyclines to prevent acneiform eruption secondary to cetuximab therapy.
authors.forename: Tamara
authors.initials: T
authors.lastname: Micantonio
authors.forename: Maria Concetta
authors.initials: MC
authors.lastname: Fargnoli
authors.forename: Enrico
authors.initials: E
authors.lastname: Ricevuto
authors.forename: Corrado
authors.initials: C
authors.lastname: Ficorella
authors.forename: Paolo
authors.initials: P
authors.lastname: Marchetti
authors.forename: Ketty
authors.initials: K
authors.lastname: Peris
mesh_terms: D017486:Acneiform Eruptions / Q000139:chemically induced / Q000473:pathology / Q000517:prevention & control*; D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D000911:Antibodies, Monoclonal / Q000009:adverse effects*; D061067:Antibodies, Monoclonal, Humanized; D000970:Antineoplastic Agents / Q000009:adverse effects*; D000068818:Cetuximab; D003875:Drug Eruptions / Q000517:prevention & control*; D006801:Humans; D008297:Male; D008875:Middle Aged; D013754:Tetracyclines / Q000627:therapeutic use*
chemical_list: D000900:Anti-Bacterial Agents; D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D000970:Antineoplastic Agents; D013754:Tetracyclines; D000068818:Cetuximab